Don't want ads? Subscribe or login now.

COVID Tester Hits BCBS Unit With Competition Counterclaims

By Bryan Koenig · June 30, 2022, 8:06 PM EDT

COVID-19 testing provider GS Labs LLC has filed competition counterclaims against Blue Cross Blue Shield's Minnesota unit, hitting back against allegations of "laboratory profiteering" by submitting inflated reimbursement claims....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Answer & Counterclaims

Case Information

Case Title

BCBSM, Inc. v. GS Labs, LLC

Case Number

0:22-cv-00513

Court

Minnesota

Nature of Suit

Labor: E.R.I.S.A.

Date Filed

March 01, 2022

Recent Articles By Bryan

October 15, 2024
'Extraordinary' Blue Cross Deal Includes $2.8B Payout
March 08, 2024
Deadline Drama Briefly Threatens Suit Against Insurer VSP
February 22, 2024
Total Vision's Antitrust Suit Against VSP Kept Largely Intact
December 21, 2023
FTC, DOJ End 2023 With New Guidance, Lingering Challenges
March 20, 2023
DOJ Quietly Abandons UnitedHealth Merger Appeal
February 15, 2023
BCBS Members Want To Duck, Pare BB&B Antitrust Suit
December 20, 2022
State Regulators Want 11th Circ. To Tweak $2.67B BCBS Deal
December 13, 2022
$2.7B BCBS Deal 'Sold Out' Some Claimants, 11th Circ. Told
November 23, 2022
4 Firms, 2 Years, 1 Suit And, Finally, A Done UnitedHealth Deal
November 21, 2022
UnitedHealth Closes Merger But DOJ Keeps Fighting